A ROS-Responsive Dual-Targeting Drug Nanocarrier Serving As a GSI Synergist and Ferroptosis Sensitizer for T-Cell Acute Lymphoblastic Leukemia.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined